| Quarter | Score |
|---|---|
| 2022-Q1 | 50.3 |
| 2022-Q3 | 41.2 |
| 2022-Q4 | 49.5 |
| 2023-Q1 | 49.7 |
| 2023-Q2 | 63.9 |
| 2023-Q3 | 48.0 |
| 2023-Q4 | 66.3 |
| 2024-Q1 | 73.5 |
| 2024-Q2 | 72.2 |
| 2024-Q3 | 57.5 |
| 2024-Q4 | 57.5 |
| 2025-Q1 | 58.7 |
| 2025-Q2 | 89.4 |
| 2025-Q3 | 86.0 |
| 2025-Q4 | 86.0 |
| 2026-Q1 | 86.1 |
| 2026-Q2 | 86.3 |
Funds reducing exposure or consensus momentum fading
Trading 32.9% below funds' estimated purchase price
2 of 18 tracked funds hold DKS. Avg conviction: 3.5%. Net trimming. First tracked at $203.25 (current -32.9% vs tracked).
Sachem Head Capital has 7.0% in this stock
Benchmark comparison unavailable
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Sachem Head Capital | 7.0% | Reduce |
| Citadel Advisors | 0.0% | Reduce |